[ Back to EurekAlert! ]

Contact: Vanessa Solomon
solomon@wehi.edu.au
61-393-452-971
Walter and Eliza Hall Institute

Dr. Guillaume Lessene, Walter and Eliza Hall Institute

Caption: Dr Guillaume Lessene and his collaborators have tailor-made a new chemical compound that blocks a protein that has been linked to poor responses to treatment in cancer patients.

Credit: Walter and Eliza Hall Institute, Australia

Usage Restrictions: None

Related news release: Discovery brings hope of new tailor-made anti-cancer agents


[ Back to EurekAlert! ]